VIRMA and breast carcinoma: Given that only VIRMA FL contributed to the phenotypic and m6A level changes in breast cancer cells, we determined whether VIRMA FL but not VIRMA N-term is enriched in the nucleus since this is where m6A methylation typically occurs[50, 51].